Developing a new non-hormonal treatment for endometriosis
Novel, Non-hormonal Therapeutic for Endometriosis
This study is working on a new treatment for endometriosis that doesn't use hormones and aims to actually change the disease instead of just easing the symptoms, and women with this condition may have a chance to join clinical trials as the research moves forward.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Endomet Biosciences, INC NIH-funded |
| Lab location | 1 site (Irvine, UNITED STATES) |
| Project ID | NIH-11300271 on NIH RePORTER |
What this research studies
This research aims to create the first disease-modifying and non-hormonal therapy for endometriosis, a condition affecting about 10% of women globally. The project addresses the limitations of current treatments, which often involve hormonal therapies that can have undesirable side effects and do not cure the disease. By focusing on a novel therapeutic approach, the research seeks to target the underlying causes of endometriosis rather than just managing symptoms. Patients may have the opportunity to participate in clinical trials as the research progresses.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with endometriosis, particularly those who have not found relief from existing hormonal treatments.
Not a fit: Patients who have not been diagnosed with endometriosis or those who have already undergone a hysterectomy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a much-needed cure for endometriosis, significantly improving the quality of life for affected women.
How similar studies have performed: While there have been various approaches to treating endometriosis, this specific non-hormonal therapeutic strategy is novel and has not been extensively tested in clinical settings.
Where this research is happening
Irvine, UNITED STATES
- Endomet Biosciences, INC — Irvine, United States (Active)
Researchers
- Principal investigator: Petrossian, Tanya Christineh — Endomet Biosciences, INC
- Study coordinator: Petrossian, Tanya Christineh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.